RecruitingNCT00807482
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease
Studying Primary ciliary dyskinesia, Kartagener type
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- Kenneth R. Olivier, MD, MPH, M.DUniversity of North Carolina, Chapel Hill
- Enrollment
- 1800 enrolled
- Eligibility
- All sexes
- Timeline
- 2004 – 2027
Study locations (1)
- The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00807482 on ClinicalTrials.gov